激素受体（HR）阳性转移性乳腺癌（mBC）.pdf

《激素受体（HR）阳性转移性乳腺癌（mBC）.pdf》由会员分享，可在线阅读，更多相关《激素受体（HR）阳性转移性乳腺癌（mBC）.pdf（158页珍藏版）》请在三个皮匠报告上搜索。

1、A Multitumor CME/MOC-,NCPD-and ACPE-Accredited Educational Conference Developed in Partnership with Florida Cancer Specialists&Research InstituteFriday,February 28,2025ModeratorNeil Love,MDFacultyAditya Bardia,MD,MPHVirginia F Borges,MD,MMScHarold J Burstein,MD,PhDJoyce OShaughnessy,MDDisclosures fo

2、r Moderator Neil Love,MDDr Love is president and CEO of Research To Practice.Research To Practice receives funds in the form of educational grants to develop CME/NCPD/ACPE activities from the following companies:AbbVie Inc,ADC Therapeutics,Alexion Pharmaceuticals,Amgen Inc,Array BioPharma Inc,a subs

3、idiary of Pfizer Inc,Arvinas,Astellas,AstraZeneca Pharmaceuticals LP,Aveo Pharmaceuticals,Bayer HealthCare Pharmaceuticals,BeiGene Ltd,Black Diamond Therapeutics Inc,Blueprint Medicines,Boehringer Ingelheim Pharmaceuticals Inc,Bristol Myers Squibb,Clovis Oncology,Coherus BioSciences,CTI BioPharma,a

4、Sobi Company,Daiichi Sankyo Inc,Eisai Inc,Elevation Oncology Inc,Exact Sciences Corporation,Exelixis Inc,Genentech,a member of the Roche Group,Genmab US Inc,Geron Corporation,Gilead Sciences Inc,GSK,Hologic Inc,ImmunoGen Inc,Incyte Corporation,Ipsen Biopharmaceuticals Inc,Janssen Biotech Inc,adminis

5、tered by Janssen Scientific Affairs LLC,Jazz Pharmaceuticals Inc,Karyopharm Therapeutics,Kite,A Gilead Company,Legend Biotech,Lilly,MEI Pharma Inc,Merck,Mersana Therapeutics Inc,Mirati Therapeutics Inc,Mural Oncology Inc,Natera Inc,Novartis,Novartis Pharmaceuticals Corporation on behalf of Advanced

6、Accelerator Applications,Novocure Inc,Nuvalent,Pfizer Inc,Pharmacyclics LLC,an AbbVie Company,Puma Biotechnology Inc,Regeneron Pharmaceuticals Inc,Rigel Pharmaceuticals Inc,R-Pharm US,Sanofi,Seagen Inc,Servier Pharmaceuticals LLC,SpringWorks Therapeutics Inc,Stemline Therapeutics Inc,Syndax Pharmace